BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 98 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,881 | -78.4% | 208 | -67.9% | 0.00% | – |
| Q2 2021 | $18,000 | -97.9% | 647 | -96.8% | 0.00% | -100.0% |
| Q1 2021 | $862,000 | -15.2% | 20,025 | -8.8% | 0.00% | 0.0% |
| Q4 2020 | $1,016,000 | +138.5% | 21,963 | +122.5% | 0.00% | +100.0% |
| Q3 2020 | $426,000 | -18.2% | 9,869 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $521,000 | +18.4% | 9,869 | -49.7% | 0.00% | 0.0% |
| Q1 2020 | $440,000 | – | 19,611 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
| APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
| Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
| Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
| Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
| AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
| First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
| Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
| Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
| AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |